FDA Approves Rutgers’ Saliva Test for COVID-19

Currently, the tests to diagnose COVID-19 require a swab from deep in the nasal passages or the back of the throat. The U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics for its test that uses saliva. The test method was developed by RUCDR with Spectrum Solutions and Accurate Diagnostic Labs (ADL).